MedTrace Logo

Bleeding Pattern Study

NCT00302666 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1315

Last updated 2009-05-18

No results posted yet for this study

Summary

The aim of this study is to evaluate bleeding pattern, cycle control, contraceptive efficacy and safety of this oral contraceptive in two different regimens of intake.

Conditions

  • Oral Contraceptive

Interventions

DRUG

Valette (Dienogest/EE30, BAY86-5038)

Oral contraceptive extended cycles

DRUG

Valette (Dienogest/EE30, BAY86-5038)

Oral contraceptive conventional cycles

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-06-30
Completion
2005-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00302666 on ClinicalTrials.gov